Appendix 3Y-Dr Anton Uvarov
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity
Actinogen Limited
ABN
14 086 778 476
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director
Dr Anton Uvarov
Date of last notice
4 December 2014
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed
in this part.
Direct or indirect interest
Direct
Nature of indirect interest
(including registered holder)
-
Note: Provide details of the circumstances
giving rise to the relevant interest.
Date of change
20 May 2015
No. of securities held prior
to change
4,029,350
Class
Fully paid ordinary shares
Number acquired
157,894
Number disposed
-
Value/Consideration
includes brokerage/gst
$15,000
Note: If consideration is non-cash, provide
details and estimated valuation
+ See chapter 19 for defined terms.
Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
No. of securities held after
change
4,187,244 fully paid ordinary shares
Nature of change
Issue of shares pursuant to share purchase plan.
Example: on-market trade, off-market trade,
exercise of options, issue of securities under
dividend reinvestment plan, participation in
buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed
in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
(if issued securities)
N/A
Date of change
N/A
No. and class of securities to N/A
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
N/A
Part 3 – +Closed period
Were the interests in the securities or contracts detailed N/A
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade N/A
to proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
Share your feedback
Discover